National Institute of Allergy and Infectious Diseases
Link to NIAID Home Page Link to NIAID Home Page Link to NIH Home Page
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Malaria Vaccine Development
 Development Strategy
 Opportunities
 Organizational Structure
 Product Development Timeline
 Product Groups
 Publications
 Units
  Antigen Development
  Clinical Trials
  Conjugation Development
  Formulation
  Immunology and Animal Studies
  Molecular Biology
  Process Development
  Quality Assurance
  Quality Control


Malaria Vaccine Development Branch

Molecular Biology Unit

The major role of the Molecular Biology Unit is to develop expression constructs and to generate all research and production clones. These expression constructs and production clones become the foundation of future candidate antigens. An additional critical role of the unit is the detailed characterization, documentation, and curation of all constructs and expression clones.

Both blood-stage and mosquito-stage transmission-blocking vaccines have been identified as potential strategies for the control of malaria. To evaluate vaccine candidates, the Molecular Biology Unit uses recombinant DNA technologies and expression systems to produce recombinant malaria proteins in support of the preclinical and clinical development pathways of MVDB.

Contact Info

Nicholas MacDonald, Ph.D.
Phone: 301-443-5742
E-mail: nmacdonald@niaid.nih.gov  

See Also

  • Division of Intramural Research (DIR)
  •  
    E-mail Icon E-mail this page
    Print Icon Print this page

    Contact Info

    Nicholas MacDonald, Ph.D.
    Phone: 301-443-5742
    E-mail: nmacdonald@niaid.nih.gov  

    See Also

  • Division of Intramural Research (DIR)